Oral VK2735 for Weight Management Phase 3 (SUNRISE 1)
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07868835. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled, 68-Week Efficacy and Safety Study of VK2735 Administered Orally for Weight Management in Participants Without Type 2 Diabetes Mellitus Who Are Obese, or Overweight With at Least One Weight-related Comorbid Condition
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is one of two planned Phase 3 studies to support the weight management indication for VK2735 Oral in obese (BMI ≥ 30 kg/m2) or overweight (BMI ≥ 27kg/m2) adults with at least one weight-related comorbidity without type 2 diabetes mellitus.
Study identification
- NCT ID
- NCT07868835
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 560 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 2026 (Estimated)
- Primary completion
- Jul 2028 (Estimated)
- Completion
- Aug 2028 (Estimated)
- Last update posted
- Nov 16, 2026
2026 – 2028
United States locations
- U.S. sites
- 20
- U.S. states
- 17
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Viking Clinical Site #1020 | Tucson | Arizona | 85741 | Recruiting |
| Viking Clinical Site #1018 | Chula Vista | California | 91910 | Recruiting |
| Viking Clinical Site #1015 | Lake Forest | California | 92630 | Recruiting |
| Viking Clinical Site #1005 | Melbourne | Florida | 32934 | Recruiting |
| Viking Clinical Site #1003 | The Villages | Florida | 32162 | Recruiting |
| Viking Clinical Site #1013 | Atlanta | Georgia | 30329 | Recruiting |
| Viking Clinical Site #1001 | Evansville | Indiana | 47714 | Recruiting |
| Viking Clinical Site #1009 | Valparaiso | Indiana | 46383 | Recruiting |
| Viking Clinical Site #1014 | Louisville | Kentucky | 40213 | Recruiting |
| Viking Clinical Site #1004 | Richfield | Minnesota | 55423 | Recruiting |
| Viking Clinical Site #1029 | Jackson | Mississippi | 39206 | Recruiting |
| Viking Clinical Site #1028 | Springfield | Missouri | 65807 | Recruiting |
| Viking Clinical Site #1006 | Rochester | New York | 14609 | Recruiting |
| Viking Clinical Site #1035 | Morehead City | North Carolina | 28557 | Recruiting |
| Viking Clinical Site #1023 | Medford | Oregon | 97504 | Recruiting |
| Viking Clinical Site #1002 | East Greenwich | Rhode Island | 02818 | Recruiting |
| Viking Clinical Site #1030 | Henderson | Tennessee | 37075 | Recruiting |
| Viking Clinical Site #1031 | Abilene | Texas | 79606 | Recruiting |
| Viking Clinical Site #1026 | Salt Lake City | Utah | 84124 | Recruiting |
| Viking Clinical Site #1011 | Seattle | Washington | 98105 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07868835, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 16, 2026 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.